APS-IgG showed no correlation between their anti-ATIII activity and their inhibitory effects on AT-III inactivation (r = -0.2), shown in Figure 4B for each individual APS-IgG sample. This evidence concerns the gene SERPINC1 and autoimmune polyendocrinopathy.